Driven & Proven Executive Team

Our highly experienced executive team is dedicated to drug research and development. 

Mr. Lange was one of the Co-Founders of Reven and helped build the management team that currently drives the company.

Mr. Denomme is a Co-Founder of Reven Pharmaceuticals with 30 years of International Executive Management experience.

Mr. Volk has 24 years of International Executive Management experience, 20 of which have been in Healthcare, Pharmaceuticals, and Biotech.

Mr. Van Wyk brings over 40 years of experience in the pharmaceutical industry, including research, development, drug design and formulation.

Mr. Halverson is known as an exceptional leader with effective management and team-building skills. As an experienced banking executive, he has an impressive 30-plus year track record of opening and growing banking organizations.

Mr. Hoffman has more than 20 years of Executive Management & Corporate Leadership experience, with a proven track record of success.

Dr. Carlson has over 40 years in the pharmaceutical industry with expertise in product development. He co-founded and later owned PRACS Institute Ltd., a contract research organization contracted by the drug industry for unbiased product evaluation for FDA submission.

Kevin McGovern is the Chairman and CEO of McGovern Capital. Through McGovern Capital and its affiliates, he has co-founded over 25 companies, six of which have become world/category leaders.

Our Advisory Board

Our medical advisory board consists of clinical experts primarily focused in cardiovascular and neurological medicine in addition to drug development. 

Jürgen Lüders, M.D.

Paul Michael Grossman, M.D.

Robert J. Kowalski, M.D., M.S., P.E.

Scott E. Woodman, M.D., Ph.D.

Our Advisory Board

Dr. Jürgen Lüders is currently employed at Saint Mary’s Mercy Health Neurosurgeon with a specialty in complex spine, epilepsy surgery and brain tumors.

 📄 View Resume

Dr. Grossman is a Professor of Internal Medicine in the Division of Cardiovascular Medicine at the University of Michigan and a staff cardiologist at the VA Ann Arbor. He is the Director of the Cardiac Catheterization Laboratory at the VA Ann Arbor, Director of the Blue Cross Blue Shield of Michigan Cardiovascular Consortium Peripheral Vascular Intervention (BMC2 PVI), and Co-director of the University of Michigan Cardiovascular Center Multidisciplinary Peripheral Arterial Disease Program. He completed his MD at the University of Nebraska, his residency at the University of California San Diego, where he also served as chief resident, and his cardiology and interventional cardiology fellowships at the University of Michigan. Dr. Grossman is an interventional cardiologist with clinical interest in catheter based treatment of coronary, peripheral arterial, structural heart and valvular heart disease. His academic interests are focused on quality improvement in management of peripheral arterial disease and therapeutic angiogenesis.

📄 View Resume

Dr. Kowalski is board certified by the American Board of Neurological Surgery and is a Fellow of both the American Association of Neurological Surgeons and the American College of Surgeons. His practice encompasses all aspects of cranial and spinal surgery with particular emphasis on motion preservation technologies, minimally invasive surgery (MIS) techniques, and spinal instrumentation.

📄 View Resume

Specializing in Melanoma Oncology, Dr. Woodman has a board certification from The American Board of Internal Medicine.

📄 View Resume